Financials Tivic Health Systems, Inc.
Equities
TIVC
US8887052095
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | -2.80% | -6.31% | -42.22% |
Mar. 25 | Transcript : Tivic Health Systems, Inc., 2023 Earnings Call, Mar 25, 2024 | |
Mar. 25 | Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 37.69 | 6.193 | 2.639 |
Enterprise Value (EV) 1 | 25.43 | 3.206 | -0.387 |
P/E ratio | -1.6 x | -0.61 x | -0.17 x |
Yield | - | - | - |
Capitalization / Revenue | 32.3 x | 3.37 x | 2.24 x |
EV / Revenue | 21.8 x | 1.74 x | -0.33 x |
EV / EBITDA | -4.52 x | -0.32 x | 0.05 x |
EV / FCF | -6,561,423 x | -575,928 x | 80,748 x |
FCF Yield | -0% | -0% | 0% |
Price to Book | 2.84 x | 1.71 x | 0.74 x |
Nbr of stocks (in thousands) | 97.2 | 96.8 | 1,466 |
Reference price 2 | 388.0 | 63.99 | 1.800 |
Announcement Date | 3/31/22 | 3/31/23 | 3/25/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 0.42 | 0.86 | 1.166 | 1.84 | 1.176 |
EBITDA 1 | -3.639 | -3.196 | -5.624 | -10.09 | -8.237 |
EBIT 1 | -3.643 | -3.204 | -5.632 | -10.1 | -8.245 |
Operating Margin | -867.38% | -372.56% | -483.02% | -548.8% | -701.11% |
Earnings before Tax (EBT) 1 | -4.146 | -3.639 | -8.493 | -10.1 | -8.244 |
Net income 1 | -4.148 | -3.639 | -8.494 | -10.1 | -8.244 |
Net margin | -987.62% | -423.14% | -728.47% | -548.7% | -701.02% |
EPS 2 | -180.3 | -158.0 | -243.2 | -104.4 | -10.40 |
Free Cash Flow | - | -0.9739 | -3.875 | -5.566 | -4.793 |
FCF margin | - | -113.24% | -332.36% | -302.51% | -407.58% |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 5/14/21 | 5/14/21 | 3/31/22 | 3/31/23 | 3/25/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|
Net sales 1 | 0.528 | 0.477 | 0.408 | 0.376 | 0.161 | 0.282 |
EBITDA | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - |
EPS | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/15/22 | 11/14/22 | 3/31/23 | 5/15/23 | 8/14/23 | 11/14/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 2.31 | 0.87 | 12.3 | 2.99 | 3.03 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | -0.97 | -3.88 | -5.57 | -4.79 |
ROE (net income / shareholders' equity) | - | -610% | -140% | -119% | -229% |
ROA (Net income/ Total Assets) | - | -87.9% | -42.5% | -60.4% | -93.4% |
Assets 1 | - | 4.139 | 19.99 | 16.71 | 8.825 |
Book Value Per Share 2 | 103.0 | -50.60 | 137.0 | 37.50 | 2.440 |
Cash Flow per Share 2 | 100.0 | 44.90 | 134.0 | 36.30 | 2.320 |
Capex 1 | 0.03 | - | - | 0.01 | 0.12 |
Capex / Sales | 7.38% | - | - | 0.6% | 10.03% |
Announcement Date | 5/14/21 | 5/14/21 | 3/31/22 | 3/31/23 | 3/25/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.22% | 1.52M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- TIVC Stock
- Financials Tivic Health Systems, Inc.